Scinai Immunotherapeutics Ltd. logo

Scinai Immunotherapeutics Ltd. (SCNI)

Market Closed
15 Oct, 08:00 PM
NASDAQ (CM) NASDAQ (CM)
$
0. 90
+0.02
+2.4432%
Pre Market
$
0. 90
-0 -0.1664%
609.99K Market Cap
- P/E Ratio
- Div Yield
369,151 Volume
- Eps
$ 0.88
Previous Close
Investors:
Add Transaction
Day Range
0.76 0.94
Year Range
0.75 15.5
Want to track SCNI and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Scinai Immunotherapeutics Ltd. (SCNI) Statistics

Valuation metrics

Market Cap 609.99K
Enterprise value 1.34M
Trailing P/E (ttm) -0
Forward P/E -
PEG ratio 0
Price/Sales (ttm) 0.41
Price/Book (mrq) 5.73
Enterprise Value/Revenue 0.9
Enterprise Value/EBITDA -0.2

Overview

Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 30.65K
Average volume (90 days) 841.54K

Price summary

52-Week low 0.75
52-Week high 15.5
Beta -
50-Day moving average 1.62
200-Day moving average 0.6

Dividends and splits

Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:10
Last split Date 21 Aug 2026

Financials

Fiscal year

Fiscal year ends -
Most recent quarter (mrq) -

Profitability

Profit margin -1.77%
Operating margin -5.64%

Operational effectiveness

Return on assets -0.15%
Return on equity -0.27%

Income Statement

Revenue (ttm) -
Revenue per share (ttm) 0.03
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.05
Quarterly earnings growth (yoy) -

Balance Sheet

Total cash (mrq) -
Total cash per share (mrq) 0.05
Total debt (mrq) -
Total Debt/Equity (mrq) 0.31
Current ratio (mrq) 1.56%
Book value per share (mrq) 0.21

Cash Flow

Cash flow statement -
Levered free cash flow (LFCF) -